- Home
- APT vs CTSO Comparison
APT vs CTSO Comparison
Compare APT & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APT
- CTSO
- Stock Information
- Founded
- APT 1983
- CTSO 1997
- Country
- APT Canada
- CTSO United States
- Employees
- APT N/A
- CTSO N/A
- Industry
- APT
- CTSO Medical/Dental Instruments
- Sector
- APT
- CTSO Health Care
- Exchange
- APT Nasdaq
- CTSO Nasdaq
- Market Cap
- APT 50.4M
- CTSO 58.6M
- IPO Year
- APT 1995
- CTSO N/A
- Fundamental
- Price
- APT $4.75
- CTSO $0.92
- Analyst Decision
- APT
- CTSO Buy
- Analyst Count
- APT 0
- CTSO 2
- Target Price
- APT N/A
- CTSO $5.50
- AVG Volume (30 Days)
- APT 20.7K
- CTSO 81.1K
- Earning Date
- APT 11-05-2025
- CTSO 11-06-2025
- Dividend Yield
- APT N/A
- CTSO N/A
- EPS Growth
- APT N/A
- CTSO N/A
- EPS
- APT 0.33
- CTSO N/A
- Revenue
- APT $58,562,000.00
- CTSO $36,107,520.00
- Revenue This Year
- APT N/A
- CTSO $11.93
- Revenue Next Year
- APT N/A
- CTSO $21.22
- P/E Ratio
- APT $14.31
- CTSO N/A
- Revenue Growth
- APT N/A
- CTSO 20.18
- 52 Week Low
- APT $4.06
- CTSO $0.71
- 52 Week High
- APT $6.20
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- APT 48.86
- CTSO 45.36
- Support Level
- APT $4.67
- CTSO $0.90
- Resistance Level
- APT $4.81
- CTSO $0.96
- Average True Range (ATR)
- APT 0.09
- CTSO 0.05
- MACD
- APT -0.01
- CTSO -0.00
- Stochastic Oscillator
- APT 35.10
- CTSO 16.75
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.